Monitor U.S. trade policies relating to intellectual property protection under the WTO TRIPS agreement
Importation of FDA-approved pharmaceuticals Taxation of International Operations of U.S. corporations generally; Homeland investment legislation; R&D tax credit;
H.R. 1424 and H.R. 7060; Monitor U.S. trade policies relating to intellectual property protection under the WTO/TRIPS agreement
H.R. 1908 Patent Reform Act of 2007
S. 1145 Patent Reform Act of 2007 Vaccine Injury Compensation Program
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the    
Pan American Health Organization; HR 3610 HR 5629 Childhood immunizations
Dietary supplement issues
Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003
Drug compounding
Alzheimer's care
Comparative effectiveness - S.3408 - Comparative Effectiveness Research Act of 2008
S. 1695 Biologics Price Competition and Innovation Act of 2007
H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act
Pediatric Studies and Trials
Drug Safety/Clinical Trials
H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007
S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics
S. 1505 - Affordable Biologics for Consumers Act
H.R. 3610 - Food and Drug Import Safety Act of 2007
S.2029 - Vaccine Safety and Payment
Health care issues
Drug approvals
Reimbursement rates
S. 334 The Healthy Americans Act
H.Con.Res. 342 (BHRT)
FDA Pre-emption
S.3613, H.R. 7114 - Independence at Home Act
S.3409-Drug and Device Accountability Act of 2008
Follow-on biologics
Drug importation and counterfeiting
Drug advertising
Comparative effectiveness
Physician payment disclosure
Hormone replacement therapies
Chronic Illness
International public health issues
International vaccine issues Vaccines
Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003
Medicare coverage of pharmaceuticals, Medicare Part D
Issues relating to Medicaid reimbursement for drugs/biologics in Title VI of S.1932-the Deficit Reduction Act of 2005
Pediatric Exclusivity
H.R. 4 - Medicare Prescription Drug Price Negotiation Act
H.R. 3162 - Children's Health and Medicare Protection Act of 2007
S.1893/H.R. 976 - Children's Health Insurance Progam Reauthorization Act of 2007
S. 2499 - Medicare, Medicaid and SCHIP Extension Act of 2007
Chronic care out of pocket costs
S. 2029 - Physician Payments Sunshine Act of 2007
HR 5605 - Physician Payments Sunshine Act of 2007
HR 2185 - Enhanced Healthcare Value for All Act
Medicare Prescription Drug Benefit
Medicaid drug rebate
Medicare Physician Reimbursement package
Medicare and Medicaid Drug Reimbursement
Medicaid Rebate
Medicaid Part D Non-Interference
H.R. 6331/S.3101 - Medicare Improvements for Patients and Providers Act of 2008
S.3118 - Preserving Access to Medicare Act of 2008
S.3613, H.R. 7114 - Independence at Home Act FDA reform proposals; Pseudoephedrine
H.R. 970 DXM Distribution Act
S. 1378 DXM Distribution Act
S. 2274 Dextromethorphan Abuse Reduction Act Monograph System Reform Proposal
S. 2274 DXM Abuse Reduction Act H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007
S. 623/HR 1038 - Access to Life-Saving Medicine Act, Follow-on Biologics
S.1695 - Biologics Price Competition and Innovation Act of 2007
S.1505- Affordable Biologics for Consumers Act H.R. 5629 - "Pathway for Biosimilars Act"
H.R. 3610 - Food and Drug Import Safety Act of 2007
S.3409 - Drug and Device Accountability Act of 2008
Biosimilars
Drug Safety
Prescription Drug Importation
Import Safety
Compoundin
TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid CSP - Consumer Issues/Safety/Products PHA - Pharmacy
136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office
WYETH
1667 K STREET NW, #1270, WASHINGTON, DC, 20006, US
JULIE RABINOWITZ LEO C JARDOT BRONWEN KAYE JULIE RABINOWITZ LEO C JARDOT ANGELA WALKER RIEMER JULIE RABINOWITZ LEO C JARDOT BRONWEN KAYE BRONWEN KAYE LEO C JARDOT JULIE RABINOWITZ ANGELA WALKER RIEMER BRONWEN KAYE LEO C JARDOT JULIE RABINOWITZ ANGELA WALKER RIEMER LEO C JARDOT ANGELA WALKER RIEMER JULIE RABINOWITZ BRONWEN KAYE LEO C JARDOT BRONWEN KAYE JULIE RABINOWITZ ANGELA WALKER RIEMER